These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7918847)

  • 1. Optimisation of a new continuous UV assay for the determination of blood coagulation factor XIII activity in human plasma.
    Heins M; Fahron U; Withold W; Rick W
    Eur J Clin Chem Clin Biochem; 1994 Jun; 32(6):479-83. PubMed ID: 7918847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A photometric assay for blood coagulation factor XIII.
    Fickenscher K; Aab A; Stüber W
    Thromb Haemost; 1991 May; 65(5):535-40. PubMed ID: 1871715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A modified, optimized kinetic photometric assay for the determination of blood coagulation factor XIII activity in plasma.
    Kárpáti L; Penke B; Katona E; Balogh I; Vámosi G; Muszbek L
    Clin Chem; 2000 Dec; 46(12):1946-55. PubMed ID: 11106327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic determination of blood coagulation Factor XIII in plasma.
    Muszbek L; Polgár J; Fésüs L
    Clin Chem; 1985 Jan; 31(1):35-40. PubMed ID: 2856900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of factor XIII activity and of factor XIII inhibitors using an ammonium-sensitive electrode.
    Hellstern P; Schilz K; von Blohn G; Wenzel E
    Thromb Haemost; 1983 Aug; 50(2):563-6. PubMed ID: 6138878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of blood coagulation factor XIII in patients with acute pulmonary embolism. Correlation of factor XIII antigen levels with pulmonary occlusion rate, fibrinogen, D-dimer, and clot firmness.
    Kucher N; Schroeder V; Kohler HP
    Thromb Haemost; 2003 Sep; 90(3):434-8. PubMed ID: 12958612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A microtiter assay for factor XIII using fibrinogen and biotinylcadaverine as substrates.
    Song YC; Sheng D; Taubenfeld SM; Matsueda GR
    Anal Biochem; 1994 Nov; 223(1):88-92. PubMed ID: 7695107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microtiter assay for measurement of factor XIII activity in plasma.
    Dempfle CE; Harenberg J; Hochreuter K; Heene DL
    J Lab Clin Med; 1992 May; 119(5):522-8. PubMed ID: 1349910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of coagulation factor XIII activity by a thio-NADH based assay using factor XIII immuno-depleted plasma as a diluent for calibration.
    Kappel A; Stephan S; Christ G; Pechmann L; Duwe C; Fischer B; Hahn M; Althaus H; Ehm M; Schwarz H; Vitzthum F
    Clin Chem Lab Med; 2010 Dec; 48(12):1739-43. PubMed ID: 20828366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity: implications of a prospective study.
    Gerlach R; Tölle F; Raabe A; Zimmermann M; Siegemund A; Seifert V
    Stroke; 2002 Jun; 33(6):1618-23. PubMed ID: 12053001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical and clinical utility of a photometric assay for blood coagulation factor XIII.
    van Wersch JW
    Eur J Clin Chem Clin Biochem; 1993 Jul; 31(7):467-71. PubMed ID: 8399788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of factor XIII activity by a new photometric assay in plasma and platelets of healthy blood donors.
    Wagner B; Seyfert UT; Gosse M; Wenzel E; Fickenscher K; Ruhl HG
    Thromb Res; 1994 Apr; 74(2):169-74. PubMed ID: 8029818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Factor XIII.
    Muszbek L; Katona É; Kerényi A
    Methods Mol Biol; 2017; 1646():277-293. PubMed ID: 28804836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A photometric method for the dosage of factor XIII applied to the study of chronic hepatopathies.
    Ballerini G; Gemmati D; Moratelli S; Morelli P; Serino ML
    Thromb Res; 1995 Jun; 78(5):451-6. PubMed ID: 7660361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simple, quick one-step ELISA assay for the determination of complex plasma factor XIII (A2B2).
    Katona E; Haramura G; Kárpáti L; Fachet J; Muszbek L
    Thromb Haemost; 2000 Feb; 83(2):268-73. PubMed ID: 10739385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma.
    Caudill JS; Nichols WL; Plumhoff EA; Schulte SL; Winters JL; Gastineau DA; Rodriguez V
    Transfusion; 2009 Apr; 49(4):765-70. PubMed ID: 19192257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of coagulation factor XIII. Critical study of the different techniques used (author's transl)].
    Soria J; Soria C; Lafay P
    Pathol Biol (Paris); 1980 May; 28(5):313-7. PubMed ID: 6770323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of a link between raised levels of pepsinogen in blood as a mediator of in-vitro clot lysis in acid and a cause of abnormal factor XIII screening tests.
    Duncan EM; Dale BJ; Lloyd JV
    Blood Coagul Fibrinolysis; 2014 Jun; 25(4):340-8. PubMed ID: 24440916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleeding disorder with abnormal wound healing, acid-soluble clots and normal factor XIII.
    Ragaz S; Kemp G; Furlan M; Beck EA
    Thromb Haemost; 1976 Dec; 36(3):537-41. PubMed ID: 1037151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.